CD8A and cancer: TEFF likely represent the majority of the TIL population in well-controlled tumors and are responsible for positive clinical responses, as adoptive transfer experiments using autologous TEFF derived from CD8+ TILs successfully eradicate tumors in cancer patients [3, 7, 9, 53, 54].